Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! Please be sure to document all clinical activities daily.
Restricted to hematology/oncology and nephrology. Strictly adhere to approved criteria for use.
Soliris, Bkemv, and Epysqli are classified as therapeutically equivalent for the FDA-approved indications. The most cost-effective product will be utilized.
Epysqli is a REMs drug and if ordered as the most cost effective option please reach out to a clinical specialist for REMS verification. More information can be obtained from the REMS info below.
Soliris medication guide
Epysqli medication guide
BKEMV medication guide
Soliris Criteria for Use
Restricted to hematology/oncology and nephrology. Strictly adhere to approved criteria for use.
Soliris, Bkemv, and Epysqli are classified as therapeutically equivalent for the FDA-approved indications. The most cost-effective product will be utilized.
Reviewed date: July 24, 2007 and 28 Feb 2017 (High Impact Committee), November 2024 ,May 2025(Epysqli)
Eculizumab-aeeb (BKEMV) Spotlight.pdf
Epysqli is a REMs drug and if ordered as the most cost effective option please reach out to a clinical specialist for REMS verification. More information can be obtained from the REMS info below.
Epysqli Healthcare Provider Safety Brochure
REMS (Soliris) : View FDA REMS Info
REMS (BKEMV): View FDA REMS info
REMS (Epysqli): View FDA REMS info